Quoin Pharmaceuticals Ltd... (QNRX)
NASDAQ: QNRX
· Real-Time Price · USD
7.32
-0.09 (-1.21%)
At close: Sep 26, 2025, 10:59 AM
-1.21% (1D)
| Bid | n/a |
| Market Cap | 4.31M |
| Revenue (ttm) | 100.37K |
| Net Income (ttm) | -12.17M |
| EPS (ttm) | 958.65 |
| PE Ratio (ttm) | 0.01 |
| Forward PE | -0.47 |
| Analyst | n/a |
| Dividends | n/a |
| Ask | n/a |
| Volume | 12,577 |
| Avg. Volume (20D) | 41,955 |
| Open | 7.35 |
| Previous Close | 7.41 |
| Day's Range | 7.10 - 7.51 |
| 52-Week Range | 5.01 - 54.95 |
| Beta | 1.85 |
| Ex-Dividend Date | n/a |
About QNRX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol QNRX
Website n/a
4 months ago
+0%
QNRX stock has given up its prior gain. Quoin Phar...
Unlock content with
Pro Subscription
4 months ago
+0%
Quoin Pharmaceuticals shares are trading higher after the company announced it received FDA clearance to initiate a second whole-body QRX003 netherton syndrome clinical study.
